Merck reported a strong set of figures, which were slightly above our expectations and beat consensus by 4-5%. The strong performance was driven by HealthCare and Life Science as Performance Materials saw a stabilisation in its profitability. Management adjusted its COVID-19-related scenario and provided a quantitative FY guidance, where AlphaValue is at the lower end of the provided range and consensus at the midpoint.
14 May 2020
HealthCare's growth momentum
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
HealthCare's growth momentum
Merck KGaA (MRCK:WBO) | 0 0 1.2% | Mkt Cap: 10,792m
- Published:
14 May 2020 -
Author:
Martin Schnee -
Pages:
3
Merck reported a strong set of figures, which were slightly above our expectations and beat consensus by 4-5%. The strong performance was driven by HealthCare and Life Science as Performance Materials saw a stabilisation in its profitability. Management adjusted its COVID-19-related scenario and provided a quantitative FY guidance, where AlphaValue is at the lower end of the provided range and consensus at the midpoint.